212 related articles for article (PubMed ID: 35327650)
1. Multicenter
Rullmann M; Brendel M; Schroeter ML; Saur D; Levin J; Perneczky RG; Tiepolt S; Patt M; Mueller A; Villemagne VL; Classen J; Stephens AW; Sabri O; Barthel H; On Behalf Of The German Imaging Initiative For Tauopathies Gii T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327650
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
3. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
4. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
5. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
[TBL] [Abstract][Full Text] [Related]
6. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
7. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
8. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
9. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
10. Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease.
Macedo AC; Durço DFPA; Tissot C; Therriault J; Vilela de Faria AO; Aumont É; Servaes S; Rahmouni N; Fernandez-Arias J; Wang YT; Lussier FZ; Bieger A; Zimmer ER; Pascoal TA; Gauthier S; Rosa-Neto P
J Prev Alzheimers Dis; 2024; 11(2):414-421. PubMed ID: 38374747
[TBL] [Abstract][Full Text] [Related]
11. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
12. The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework.
Macedo AC; Tissot C; Therriault J; Servaes S; Wang YT; Fernandez-Arias J; Rahmouni N; Lussier FZ; Vermeiren M; Bezgin G; Vitali P; Ng KP; Zimmer ER; Guiot MC; Pascoal TA; Gauthier S; Rosa-Neto P
J Nucl Med; 2023 Aug; 64(8):1171-1178. PubMed ID: 37321820
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
14. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
[TBL] [Abstract][Full Text] [Related]
15. One-Year Longitudinal Changes in Tau Accumulation on [
Oh M; Oh SJ; Lee SJ; Oh JS; Seo SY; Ryu S; Roh JH; Lee JH; Kim JS
J Nucl Med; 2024 Mar; 65(3):453-461. PubMed ID: 38302152
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
[TBL] [Abstract][Full Text] [Related]
17. The spatial extent of tauopathy on [
Gérard T; Colmant L; Malotaux V; Salman Y; Huyghe L; Quenon L; Dricot L; Ivanoiu A; Lhommel R; Hanseeuw B
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1662-1674. PubMed ID: 38228971
[TBL] [Abstract][Full Text] [Related]
18. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review.
Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E
Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963
[TBL] [Abstract][Full Text] [Related]
19. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.
Abey A; Davies D; Goldsbury C; Buckland M; Valenzuela M; Duncan T
Brain Pathol; 2021 Jan; 31(1):144-162. PubMed ID: 32810333
[TBL] [Abstract][Full Text] [Related]
20. Biomarker modeling of Alzheimer's disease using PET-based Braak staging.
Therriault J; Pascoal TA; Lussier FZ; Tissot C; Chamoun M; Bezgin G; Servaes S; Benedet AL; Ashton NJ; Karikari TK; Lantero-Rodriguez J; Kunach P; Wang YT; Fernandez-Arias J; Massarweh G; Vitali P; Soucy JP; Saha-Chaudhuri P; Blennow K; Zetterberg H; Gauthier S; Rosa-Neto P
Nat Aging; 2022 Jun; 2(6):526-535. PubMed ID: 37118445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
